close
close
Arkema: This French Chemical Company Is Now Cheap Enough to Go Long (OTCMKTS:ARKAF)

This article was written by

Investment Doctor's profile picture

The Investment Doctor is a financial journalist highlighting European small caps with an investment horizon of 5 to 7 years. He strongly believes that a portfolio should consist of a mix of dividend and growth stocks.

He leads the investment group European Small Cap Ideas, which provides exclusive access to actionable research on attractive, Europe-focused investment opportunities not available elsewhere. The focus is on high quality ideas in the small cap space, with an emphasis on capital gains and dividend income for consistent cash flow. Features include: two model portfolios – the European Small Cap Ideas Portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about European investment opportunities, and an active chat room to discuss the latest portfolio holdings developments. Learn more.

Analyst Disclosure: I/we do not have any equity, options or similar derivative positions in any of the companies mentioned and do not intend to enter into any such positions within the next 72 hours. I wrote this article myself and it expresses my own opinion. I receive no compensation for this (except from Seeking Alpha). I have no business relationship with any company whose shares are mentioned in this article.

I don’t have a position in Arkema’s common stock, but I have written some put options that could allow me to go long if they expire in the money.

I’m looking for Alpha’s disclosure: Past performance is no guarantee of future results. No recommendation or advice is given as to whether an investment is suitable for a particular investor. The views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker, or U.S. investment advisor or investment bank. Our analysts are third-party authors, including both professional investors and individual investors, who may not be licensed or certified by any institution or regulator.

Leave a Reply

Your email address will not be published. Required fields are marked *